June 26, 2025AstraZeneca's New Phase I Study on AZD5492: What Investors Need to Know ~1 min.AstraZeneca PLC has recently announced positive results from a Phase I study on its new drug candidate, AZD5492....
March 20, 2025AstraZeneca AZN: Among the Best Diabetes Stocks to Buy According to Billionaires ~1 min.AstraZeneca PLC (AZN) has been recognized as one of the best diabetes stocks to buy by billionaires....
March 16, 2025AstraZeneca's Experimental Blood Pressure Drug Could Become a Blockbuster ~2 min.AstraZeneca PLC (NASDAQ:AZN) has recently developed an experimental drug for treating high blood pressure, which experts believe has a strong potential to become a blockbuster in the pharmaceutical market....
March 15, 2025AstraZeneca's Experimental Blood Pressure Drug Shows Promising Results, Outperforms Broader Market ~1 min.AstraZeneca PLC's recent experimental blood pressure drug has shown promising results, performing significantly better than the broader market....
March 14, 2025AstraZeneca's Imfinzi success a step towards revolutionizing cancer treatment ~2 min.AstraZeneca PLC (AZN) continues to make significant strides in the field of cancer treatment with its groundbreaking drug, Imfinzi....
March 5, 2025ASTRAZENECA PLC Stock Hits Price Target Forecast with 13.63% Profit ~1 min.On January 28, 2025, QuantWave issued a long signal for ASTRAZENECA PLC stock when it was trading at 68.61 $....
March 4, 2025ASTRAZENECA PLC Hits Price Target Forecast with 13.62% Profit: A Sign of QuantWave's Accuracy ~2 min.ASTRAZENECA PLC (AZN) recently reached the price target forecast set by QuantWave on March 4, 2025, resulting in a profit of 13.62% for investors who followed the long signal issued on February 4, 2025....
February 28, 2025AstraZeneca PLC AZN: A Global Pharmaceutical Giant with Promising Growth Potential ~2 min.AstraZeneca PLC (AZN) is a renowned multinational pharmaceutical company with a strong presence in the global market....
February 26, 2025AstraZeneca PLC's Groundbreaking Research Leads to Exciting Discoveries in the Field of Medicine ~2 min.AstraZeneca PLC, a leading pharmaceutical company, has made significant advancements in the field of medicine through its groundbreaking research....
February 24, 2025AstraZeneca PLC Announces Positive Results from Clinical Trial ~2 min.AstraZeneca PLC, a leading pharmaceutical company, announced today that its latest clinical trial for a new drug has yielded positive results....
February 2, 2025Shareholders of AstraZeneca PLC Should Contact Levi Korsinsky Before February 21 2025 to Discuss Your Rights ~2 min.It has come to light that shareholders of AstraZeneca PLC (AZN) are urged to contact Levi Korsinsky, a renowned law firm specializing in securities litigation, before February 21, 2025, to discuss their rights. AstraZeneca PLC, a global pharmaceutical company, has been facing potential legal implications due to recent developments in the industry. Levi Korsinsky is currently investigating possible...
January 25, 2025AstraZeneca PLC Faces Class Action Lawsuit for Investor Recovery ~2 min.Robbins LLP, a leading investor rights law firm, is encouraging shareholders of AstraZeneca PLC (AZN) who have suffered significant financial losses to seek legal counsel in the ongoing class action lawsuit against the company. The lawsuit, filed by Levi Korsinsky, aims to recover damages for investors who suffered losses due to alleged misleading statements and omissions made by AstraZeneca regar...
December 31, 2024Investors Encouraged to Join Class Action Lawsuit Against AstraZeneca PLC ~1 min.Shareholders who have suffered financial losses with AstraZeneca PLC (AZN) are being urged to join a class-action lawsuit....
January 26, 2025Class Action Filed Against AstraZeneca PLC AZN Seeking Recovery for Investors ~1 min.Robbins LLP Encourages AZN Shareholders with Large Losses to Seek Counsel in the AstraZeneca PLC Class Action....
January 2, 2025AstraZeneca PLC: Driving Innovation in the Pharmaceutical Industry ~2 min.AstraZeneca PLC (AZN) has established itself as a leading pharmaceutical company with its groundbreaking research and development....
